Showing results (121-130 of 142) with videos related to
Sort By:
Pageof 15
Lymphatic Research and Biology|April 18, 2019
LIMPRINT: The UK Experience-Subjective Control of Swelling in Patients Attending Specialist Lymphedema ServicesChristine J Moffatt, Vaughan Keeley, Andrew Hughes, et al.Lymphatic Research and Biology|April 18, 2019
LIMPRINT in Specialist Lymphedema Services in United Kingdom, France, Italy, and TurkeyVaughan Keeley, Peter Franks, Isabelle Quere, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 23, 2011
Evaluation and prognostic significance of circulating tumor cells in patients with non-small-cell lung cancerMatthew G Krebs, Robert Sloane, Lynsey Priest, et al.Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2011
Analysis of circulating tumor cells in patients with non-small cell lung cancer using epithelial marker-dependent and -independent approachesMatthew G Krebs, Jian-Mei Hou, Robert Sloane, et al.The American Journal of Pathology|July 25, 2009
Evaluation of circulating tumor cells and serological cell death biomarkers in small cell lung cancer patients undergoing chemotherapyJian-Mei Hou, Alastair Greystoke, Lee Lancashire, et al.The Journal of Clinical Endocrinology and Metabolism|December 2, 2022
Association of Longitudinal Activity Measures and Diabetes Risk: An Analysis From the National Institutes of Health All of Us Research ProgramAndrew S Perry, Jeffrey S Annis, Hiral Master, et al.Plos Neglected Tropical Diseases|August 19, 2017
The location of Australian Buruli ulcer lesions-Implications for unravelling disease transmissionArvind Yerramilli, Ee Laine Tay, Andrew J Stewardson, et al.Histopathology|June 25, 2010
Cytoplasmic beta-catenin accumulation is a good prognostic marker in upper and lower gastrointestinal adenocarcinomasMichael G A Norwood, Neil Bailey, Manoj Nanji, et al.NPJ Genomic Medicine|June 29, 2018
Signaling pathway screening platforms are an efficient approach to identify therapeutic targets in cancers that lack known driver mutations: a case report for a cancer of unknown primary originPedro Torres-Ayuso, Sudhakar Sahoo, Garry Ashton, et al.BMC Medical Research Methodology|October 18, 2023
Adjusting expected deaths for mortality displacement during the COVID-19 pandemic: a model based counterfactual approach at the level of individualsRichard James Holleyman, Sharmani Barnard, Clarissa Bauer-Staeb, et al.Pageof 15